Background The prevalence of opioid-associated morbidity and mortality underscores the
need for research on non-opioid treatments for chronic non-cancer pain (CNCP). Pain is the …

Objective Health care providers are likely to see an increase in the concomitant use of
cannabis and opioids, particularly with the increased liberalization and ongoing research …

Background There is increasing debate about cannabis use for medical purposes, including
for symptomatic treatment of chronic pain. We investigated patterns and correlates of …

Background: Chronic non-cancer pain (CNCP) is estimated to affect 20% of the adult
population. Current United States and Canadian Chronic non-cancer pain guidelines …

Background Cannabis is increasingly available and used for medical and recreational
purposes, but few studies have assessed provider knowledge, attitudes, and practice …

Background Interest in the use of cannabis and cannabinoids to treat chronic non-cancer
pain is increasing, because of their potential to reduce opioid dose requirements. We aimed …

Introduction: Prescription drug overdoses are the leading cause of accidental death in the
United States. Alternatives to opioids for the treatment of pain are necessary to address this …

There has been a surge in interest in medicinal cannabis in Canada. We conducted a
questionnaire survey to determine the current prevalence of medicinal cannabis use among …

Background Cannabis has been linked to reduced opioid use, although reasons for
cannabis use among adults prescribed opioids are unclear. Aims The purpose of this study …

Purpose To characterize cannabis use among cancer patients, we aimed to describe 1)
patterns of cannabis use across multiple cancer sites; 2) perceived goals, benefits, harms of …